(Q37981941)

26 August 2017

NF-κB as a potential therapeutic target in microbial diseases (English)

1 reference

26 August 2017

0 references

4

Stefania Galdiero

1 reference

PubMed ID

22311336

26 August 2017

Massimiliano Galdiero

series ordinal

5

object named as

Massimiliano Galdiero

1 reference

26 August 2017

1

Mariateresa Vitiello

1 reference

26 August 2017

3

Emiliana Finamore

1 reference

26 August 2017

Marilena Galdiero

2

1 reference

26 August 2017

6 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

4

1 reference

26 August 2017

1108-1120

1 reference

Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus

26 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Crosstalk in NF-κB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inflammation meets cancer, with NF-κB as the matchmaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-κB and innate immunity in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Structure, regulation and function of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

I kappa B proteins: structure, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Introduction to NF-kappaB: players, pathways, perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

An innate sense of danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Macrophage activation by endogenous danger signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

CD40 regulates the processing of NF-kappaB2 p100 to p52

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Dynamic protein complexes regulate NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Resolution of inflammation: the beginning programs the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inflammation as "common soil" of the multifactorial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NFkappaB-dependent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Viral fusion peptides induce several signal transduction pathway activations that are essential for interleukin-10 and beta-interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Global progress in infectious disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Using nanotechniques to explore microbial surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Recognition of bacterial peptidoglycan by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Eukaryotic cell signaling and transcriptional activation induced by bacterial porins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

beta-Barrel membrane bacterial proteins: structure, function, assembly and interaction with lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Multiple facets of bacterial porins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The role of porins in neisserial pathogenesis and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Porins from Salmonella enterica serovar Typhimurium activate the transcription factors activating protein 1 and NF-kappaB through the Raf-1-mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Role of surface-exposed loops of Haemophilus influenzae protein P2 in the mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Monocytic activation of protein tyrosine kinase, protein kinase A and protein kinase C induced by porins isolated from Salmonella enterica serovar Typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Bartonella henselae induces NF-kappaB-dependent upregulation of adhesion molecules in cultured human endothelial cells: possible role of outer membrane proteins as pathogenic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Nuclear factor-kappa B directs carcinoembryonic antigen-related cellular adhesion molecule 1 receptor expression in Neisseria gonorrhoeae-infected epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

c-Jun NH2-terminal kinase-mediated signaling is essential for Pseudomonas aeruginosa ExoS-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Covert operations of uropathogenic Escherichia coli within the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Proteases of Porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: a review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Nuclear factor-kappaB p50 subunits in chronic periodontitis and Porphyromonas gingivalis lipopolysaccharide-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Type 1 interferons and the virus-host relationship: a lesson in détente .

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Hepatitis C virus (HCV): a review of immunological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Mechanisms of NF-kappaB activation by the HTLV type 1 tax protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

HTLV-1 tax-induced NF-kappaB activation is synergistically enhanced by 12-O-tetradecanoylphorbol-13-acetate: mechanism and implications for Tax oncogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Hepatitis B virus X protein enhances NFkappaB activity through cooperating with VBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappa B and HIV: linking viral and immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Viral appropriation of apoptotic and NF-kappaB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-κB/Rel: agonist and antagonist roles in HIV-1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB signaling modulation by EBV and KSHV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

KSHV vFLIP is essential for the survival of infected lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Molecular Genetic Analysis of Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein-induced NF-κB Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Identification of the RelA domain responsible for action of a new NF-kappaB inhibitor DHMEQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Drugs in development for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

JNK2 and IKKbeta are required for activating the innate response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Active NF-kappaB signalling is a prerequisite for influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Caspase 3 activation is essential for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB signaling differentially regulates influenza virus RNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB signaling, liver disease and hepatoprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB in liver diseases: a target for drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Regulatory mechanisms of viral hepatitis B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Antiviral activity of cyclopentenone prostanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inhibitors of NF-kappaB signaling: 785 and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inhibiting NF-κB activation by small molecules as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

New regulators of NF-kappaB in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Coming of age: anti-cytokine therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Novel IkB kinase inhibitors for treatment of nuclear factor-kB-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

The IKK NF-kappa B system: a treasure trove for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Integrating cell-signalling pathways with NF-kappaB and IKK function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Nuclear factor kappa B: a potential target for anti-HIV chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Denbinobin, a naturally occurring 1,4-phenanthrenequinone, inhibits HIV-1 replication through an NF-kappaB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Modulation of NF-κB signalling by microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Potential pharmacological control of the NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Engineering liposomes and nanoparticles for biological targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Progress in antiretroviral drug delivery using nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

PathogenicNeisseriaTrigger Expression of Their Carcinoembryonic Antigen-related Cellular Adhesion Molecule 1 (CEACAM1; Previously CD66a) Receptor on Primary Endothelial Cells by Activating the Immediate Early Response Transcription Factor, Nuclear Fa

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

Influenza viruses and MAP kinase cascades – Novel targets for an antiviral intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05335G

21 January 2018

Identifiers

DOI

10.1039/C2MB05335G

1 reference

26 August 2017

1 reference

PubMed ID

22311336